The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application

Human mesenchymal stem cells derived from Wharton’s jelly (WJ-MSCs) were used for the treatment of the ischemic-compression model of spinal cord injury in rats. To assess the effectivity of the treatment, different dosages (0.5 or 1.5 million cells) and repeated applications were compared. Cells or...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Int J Mol Sci
Autori principali: Krupa, Petr, Vackova, Irena, Ruzicka, Jiri, Zaviskova, Kristyna, Dubisova, Jana, Koci, Zuzana, Turnovcova, Karolina, Machova Urdzikova, Lucia, Kubinova, Sarka, Rehak, Svatopluk, Jendelova, Pavla
Natura: Artigo
Lingua:Inglês
Pubblicazione: MDPI 2018
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5983761/
https://ncbi.nlm.nih.gov/pubmed/29772841
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms19051503
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi